{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:09:08Z","timestamp":1781240948948,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12350-020-02356-1","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T17:03:01Z","timestamp":1601485381000},"page":"741-749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["18F-fluoride PET\/MR in cardiac amyloid: A comparison study with aortic stenosis and age- and sex-matched controls"],"prefix":"10.1016","volume":"29","author":[{"given":"Jack P.M.","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanni","family":"Trivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Spath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"MacNaught","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhairi K.","family":"Doris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Pawade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin J.R.","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lucatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Dweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02356-1_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-020-02356-1_bib2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1007\/s12350-020-02356-1_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study","volume":"140","author":"Skinner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1007\/s12350-020-02356-1_bib4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-020-02356-1_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","article-title":"Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis","volume":"9","author":"Longhi","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02356-1_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: Prevalence and prognosis in patients undergoing surgical aortic valve replacement","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02356-1_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcin.2012.03.012","article-title":"Pathology of transcatheter valve therapy","volume":"5","author":"Nietlispach","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1007\/s12350-020-02356-1_bib8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","article-title":"Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis","volume":"58","author":"Dweck","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02356-1_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","article-title":"Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease","volume":"56","author":"Azevedo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02356-1_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2014.02.612","article-title":"Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement","volume":"64","author":"Barone-Rochette","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02356-1_bib11","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jcmg.2016.10.007","article-title":"Myocardial fibrosis and cardiac decompensation in aortic stenosis","volume":"10","author":"Chin","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02356-1_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02356-1_bib13","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1007\/s12350-020-02356-1_bib14","first-page":"332","article-title":"Fluorine-18: A new isotope for bone scanning","volume":"3","author":"Blau","year":"1962","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02356-1_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0001-2998(72)80005-9","article-title":"18 F-fluoride for bone imaging","volume":"2","author":"Blau","year":"1972","journal-title":"Semin Nucl Med"},{"key":"10.1007\/s12350-020-02356-1_bib16","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s12350-017-0799-x","article-title":"Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis","volume":"25","author":"Morgenstern","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02356-1_bib17","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2016.09.953","article-title":"F-Sodium Fluoride PET\/MR for the assessment of cardiac amyloidosis","volume":"68","author":"Trivieri","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02356-1_bib18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jcmg.2016.09.029","article-title":"Coronary artery PET\/MR imaging: Feasibility, limitations, and solutions","volume":"10","author":"Robson","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02356-1_bib19","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaf246","article-title":"Joint cardiac and respiratory motion estimation for motion-corrected cardiac PET-MR","volume":"64","author":"Kolbitsch","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1007\/s12350-020-02356-1_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005131","article-title":"Optimization and reproducibility of aortic valve 18F-fluoride positron emission tomography in patients with aortic stenosis","volume":"9","author":"Pawade","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02356-1_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02356-1_bib22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2015.06.1325","article-title":"Valvular (18)F-fluoride and (18)F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis","volume":"66","author":"Jenkins","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02356-1_bib23","unstructured":"Abulizi M, Sifaoui I, Wuliya-Gariepy M et al. F-sodium fluoride PET\/MRI myocardial imaging in patients with suspected cardiac amyloidosis. J Nucl Cardiol 2019."},{"key":"10.1007\/s12350-020-02356-1_bib24","unstructured":"Martineau P, Finnerty V, Giraldeau G, Authier S, Harel F, Pelletier-Galarneau M. Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis. J Nucl Cardiol 2019."},{"key":"10.1007\/s12350-020-02356-1_bib25","doi-asserted-by":"crossref","unstructured":"Lilleness B, Doros G, Ruberg FL, Sanchorawala V. Establishment of brain natriuretic peptide\u2014based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis. Br J Haematol 2019.","DOI":"10.1111\/bjh.16198"},{"key":"10.1007\/s12350-020-02356-1_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2018-06-858951","article-title":"Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis","volume":"133","author":"Lilleness","year":"2019","journal-title":"Blood"},{"key":"10.1007\/s12350-020-02356-1_bib27","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-020-02356-1_bib28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2011.12.037","article-title":"Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology","volume":"59","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02356-1_bib29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"key":"10.1007\/s12350-020-02356-1_bib30","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/ncomms8495","article-title":"Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography","volume":"6","author":"Irkle","year":"2015","journal-title":"Nat Commun"},{"key":"10.1007\/s12350-020-02356-1_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008574","article-title":"Molecular coronary plaque imaging using","volume":"12","author":"Moss","year":"2019","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02356-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123002805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123002805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:09:42Z","timestamp":1761026982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123002805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1071358123002805"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02356-1","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-fluoride PET\/MR in cardiac amyloid: A comparison study with aortic stenosis and age- and sex-matched controls","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02356-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by ELSEVIER INC. on behalf of American Society of Nuclear Cardiology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}